Geometric accuracy in three‐dimensional coordinates of Leksell stereotactic skull frame with wide‐bore 1.5‐T MRI compared with conventional 1.5‐T MRI

The use of 1.5‐tesla (T) magnetic resonance (MR) imaging with a wide and simultaneously short bore enhances patient comfort compared with traditional 1.5‐T MR imaging and is becoming increasingly available in stereotactic radiosurgery treatment planning. However, the geometric accuracy seems unavoidably worse in wide‐bore MR imaging than in conventional MR imaging. We assessed the geometric distortion of the stereotactic image attached on a Leksell skull frame in conventional and wide‐bore 1.5‐T MR imaging. Two kinds of acrylic phantoms were placed on the skull frame and were scanned using computed tomography (CT) and conventional and wide‐bore 1.5‐T MR imaging. The three‐dimensional coordinates on both MR imaging were compared with those on CT. Deviations of measured coordinates at selected points (x = 50, 100, 150 mm; y = 50, 100, 150 mm) were indicated on different axial planes (z = 50, 75, 100, 125, 150 mm). The differences of coordinates were less than 1.0 mm in the entire treatable area for conventional MR imaging. With the large bore system, the differences of the coordinates were less than 1.0 mm around the center but substantially exceeded 1.0 mm in the peripheral regions. Further study is needed to increase the geometric accuracy of wide‐bore MR imaging for stereotactic radiosurgery treatment planning.     

Gamma-knife radiosurgery for trigeminal neuralgia

Gamma knife was installed at the PD Hinduja National Hospital and Medical Research Centre, Mumbai, India, in January 1997. In the first year of gamma-knife radiosurgery to January 1998, we treated 110 patients, of whom six had medically refractory trigeminal neuralgia. Seven treatments were administered to this group of six patients (one had bilateral neuralgia). This report evaluates the effectiveness of radiosurgery treatment in these patients. The median age of the patients was 56 years and there were five males and one female. Following Leksell stereotactic frame fixation, a magnetic resonance imaging scan was done in all. The Leksell gamma plan was used for planning. A radiosurgery dose of 70–80 Gy was delivered to the trigeminal root entry zone, 2–4 mm anterior to the junction of the pons and trigeminal nerve with a single 4 mm collimator helmet. Complete pain relief was achieved in four patients. Two had partial relief. No patient developed any radiosurgery related morbidity during the follow-up period of 5–16 months. Radiosurgery seems to be an effective approach for medically or surgically refractory trigeminal neuralgia.     

IRLED-Based Patient Localization for Linac Radiosurgery

Purpose: Currently, precise stereotactic radiosurgery delivery is possible with the Gamma Knife or floor-stand linear accelerator (linac) systems. Couch-mounted linac radiosurgery systems, while less expensive and more flexible than other radiosurgery delivery systems, have not demonstrated a comparable level of precision. This article reports on the development and testing of an optically guided positioning system designed to improve the precision of patient localization in couch-mounted linac radiosurgery systems.Methods and Materials: The optically guided positioning system relies on detection of infrared light-emitting diodes (IRLEDs) attached to a standard target positioner. The IRLEDs are monitored by a commercially available camera system that is interfaced to a personal computer. An IRLED reference is established at the center of stereotactic space, and the computer reports the current position of the IRLEDs relative to this reference position. Using this readout from the computer, the correct stereotactic coordinate can be set directly.Results: Bench testing was performed to compare the accuracy of the optically guided system with that of a floor-stand system, that can be considered an absolute reference. This testing showed that coordinate localization using the IRLED system to track translations agreed with the absolute to within 0.1 ± 0.1 mm. As rotations for noncoplanar couch angles were included, the inaccuracy was increased to 0.2 ± 0.1 mm.Conclusions: IRLED technology improves the accuracy of patient localization relative to the linac isocenter in comparison with conventional couch-mounted systems. Further, the patient’s position can be monitored in real time as the couch is rotated for all treatment angles. Thus, any errors introduced by couch inaccuracies can be detected and corrected.     

Clinical evaluation of targeting accuracy of gamma knife radiosurgery in trigeminal neuralgia

PURPOSE: The efficiency of radiosurgery is related to its highly precise targeting. We assessed clinically the targeting accuracy of radiosurgical treatment with the Leksell Gamma Knife for trigeminal neuralgia. We also studied the applied radiation dose within the area of focal contrast enhancement on the trigeminal nerve root following radiosurgery. METHODS AND MATERIALS: From an initial group of 78 patients with trigeminal neuralgia treated with gamma knife radiosurgery using a 90-Gy dose, we analyzed a subgroup of 65 patients for whom 6-month follow-up MRI showed focal contrast enhancement of the trigeminal nerve. Follow-up MRI was spatially coregistered to the radiosurgical planning MRI. Target accuracy was assessed from deviation of the coordinates of the intended target compared with the center of enhancement on postoperative MRI. Radiation dose delivered at the borders of contrast enhancement was evaluated. RESULTS: The median deviation of the coordinates between the intended target and the center of contrast enhancement was 0.91 mm in Euclidean space. The radiation doses fitting within the borders of the contrast enhancement of the trigeminal nerve root ranged from 49 to 85 Gy (median value, 77 +/- 8.7 Gy). CONCLUSIONS: The median deviation found in clinical assessment of gamma knife treatment for trigeminal neuralgia is low and compatible with its high rate of efficiency. Focal enhancement of the trigeminal nerve after radiosurgery occurred in 83% of our patients and was not associated with clinical outcome. Focal enhancement borders along the nerve root fit with a median dose of 77 +/- 8.7 Gy.     

Physics of rotating gamma systems for stereotactic radiosurgery

PURPOSE: The purpose of this study was to evaluate the characteristics of a new rotating gamma system for stereotactic radiosurgery by comparison with a well accepted system. METHODS AND MATERIALS: A novel gamma unit for stereotactic radiosurgery has been developed and distributed to 15 hospitals in China. The unit contains 30 cobalt-60 gamma radiation sources with initial activity of 200 Ci (7.4 x 10(12) Bq) each. The sources are positioned along 30 arcs, and rotate continuously as a group in an axis orthogonal to the patient's body. Measurements have been made on a representative unit installed in the Auhai Radiosurgery Center at the Beijing Navy General Hospital in the People's Republic of China. Ionization chambers calibrated by an American accredited dosimetry calibration laboratory were used for these measurements, as well as radiochromic film and thermoluminescent dosimeters. The unit tested utilizes collimators of nominal diameters of 4, 8, 14, and 18 mm. Radiochromic film samples from a Leksell Model U Gamma Knife were evaluated by the same laboratory and are presented for comparison. The treatment planning system was not evaluated. RESULTS: Radiation-absorbed dose rates and profiles measured for this unit are comparable to those previously measured with the same techniques for the Leksell Model U Gamma Knife units in San Diego and Atlanta. CONCLUSION: This unit is capable of producing well collimated beams of high energy photons, suitable for stereotactic radiosurgery. It has similar physical characteristics to those previously reported for the Leksell Model U Gamma Knife unit.     

Quality control of the stereotactic radiosurgery procedure with the polymer-gel dosimetry.

PURPOSE: To assess the entire geometric and dosimetric (relative) uncertainties of the radiosurgery procedure with the Leksell gamma knife. MATERIALS AND METHODS: The entire Leksell gamma knife stereotactic radiosurgery treatment procedure was simulated with the use of a special water filled head phantom and polymer-gel dosimeter evaluated by nuclear magnetic resonance (NMR). A test vessel filled with the polymer-gel dosimeter was fixed in the head phantom. The phantom underwent stereotactic NMR imaging, treatment planning and then irradiation according to the treatment plan prepared exactly the same way as in the ordinary treatment procedure for a patient. The treatment plan was represented by one isocenter positioned approximately centrally in the head phantom. This procedure was subsequently repeated for all four collimators (4, 8, 14, 18mm) used on the Leksell gamma knife. Evaluation of dosimeters was performed on a Siemens EXPERT 1T NMR scanner. Dose profiles in X, Y and Z axes through the ellipsoidal shaped dose distribution were obtained to compare experimental results from the irradiated phantom with the treatment planning system calculations. RESULTS: Reasonable agreement was observed between the treatment planning system calculations of relative dose distribution and the measured data. The maximum observed deviation in the spatial position between the center of the measured and calculated dose profiles was 0.6mm. The maximum observed difference in full width of half maximum between calculated and measured profiles was 1.2mm. CONCLUSIONS: The use of polymer-gel dosimetry for a verification of stereotactic procedures has some unique advantages that can be summarized as follows: the dosimeter itself is tissue equivalent, three-dimensional dose distributions can be measured and the dosimeter allows simulation of the patient's procedures without any limitations.     

Treatment volume shaping with selective beam blocking using the Leksell gamma unit

The Leksell gamma unit at the University of Pittsburgh uses 201 highly focused 60Co beams arranged in a hemispherical array. Selective beam blocking can be used to modify the treatment volume into ellipsoid shapes oriented in different directions to match better the shape of the target volume. Dose distributions for different blocking patterns were calculated using specially developed computerized 3-D treatment planning software. The changes in dose distribution with different blocking patterns predicted by computer were verified by film densitometry. Techniques for using selective beam blocking to match more closely the treatment volume to the intended target volume have the potential of reducing the likelihood of complications for radiosurgery with the Leksell gamma unit and need to be further developed.     

Radiosurgery for re-irradiation of brain metastasis: results in 54 patients.

PURPOSE: To evaluate in terms of probabilities of local-regional control and survival, as well as of treatment-related toxicity, results of radiosurgery for brain metastasis arising in previously irradiated territory. PATIENTS AND METHODS: Between January 1994 and March 2000, 54 consecutive patients presenting with 97 metastases relapsing after whole brain radiotherapy (WBRT) were treated with stereotactic radiotherapy. Median interval between the end of WBRT and radiosurgery was 9 months (range 2-70). Median age was 53 years (24-80), and median Karnofski performance status (KPS) 70 (60-100). Forty-seven patients had one radiosurgery, five had two and two had three. Median metastasis diameter and volume were 21 mm (6-59) and 1.2 cc (0.1-95.2), respectively. A Leksell stereotactic head frame (Leksell Model G, Elektra, Instrument, Tucker, GA) was applied under local anesthesia. Irradiation was delivered by a gantry mounted linear accelerator (linacs) (Saturne, General Electric). Median minimal dose delivered to the gross disease was 16.2 Gy (11.8-23), and median maximal dose 21.2 Gy (14- 42). RESULTS: Median follow-up was 9 months (1-57). Five metastases recurred. One- and 2-year metastasis local control rates were 91.3 and 84% and 1- and 2-year brain control rates were 65 and 57%, respectively. Six patients died of brain metastasis evolution, and three of leptomeningeal carcinomatosis. One- and 2-year overall survival rates were 31 and 28%, respectively. According to univariate analysis, KPS, RPA class, SIR score and interval between WBRT and radiosurgery were prognostic factors of overall survival and brain free-disease survival. According to multivariate analysis, RPA was an independent factor of overall survival and brain free-disease survival, and the interval between WBRT and radiosurgery longer than 14 months was associated with longer brain free-disease survival. Side effects were minimal, with only two cases of headaches and two of grade 2 alopecia. CONCLUSION: Salvage radiosurgery of metastasis recurring after whole brain irradiation is an effective and accurate treatment which could be proposed to patients with a KPS>70 and a primary tumour controlled or indolent. We recommend that a dose not exceeding 14 Gy should be delivered to an isodose representing 70% of the maximal dose since local control observed rate was similar to that previously published in literature with upper dose and side effects were minimal.     

Frame Slippage Verification in Stereotactic Radiosurgery

Purpose: To develop a method for detecting frame slippage in stereotactic radiosurgery by interactively matching in three dimensions Digitally Reconstructed Radiographs (DRRs) to portal images.Methods and Materials: DRRs are superimposed over orthogonal edge-detected portal image pairs obtained prior to treatment. By interactively manipulating the CT data in three dimensions (rotations and translations) new DRRs are generated and overlaid with the orthogonal portal images. This method of matching is able to account for ambiguities due to rotations and translations outside of the imaging plane. The matching procedure is performed with anatomical structures, and is used in tandem with a fiducial marker array attached to the stereotactic frame. The method is evaluated using portal images simulated from patient CT data and then tested using a radiographic head phantom.Results: For simulation tests a mean radial alignment error of 0.82 mm was obtained with the 3D matching method compared to a mean error of 3.52 mm when using conventional matching techniques. For the head phantom tests the mean alignment displacement error for each of the stereotactic coordinates was found to be Δx = 0.95 mm, Δy = 1.06 mm, Δz = 0.99 mm, with a mean error radial of 1.94 mm (SD = 0.61 mm).Conclusion: Results indicate that the accuracy of the system is appropriate for stereotactic radiosurgery, and is therefore an effective tool for verification of frame slippage.     

Three-dimensional dose mapping from gamma knife treatment using a dosimeter gel and MR-imaging.

A new method has been investigated for the mapping of dose distributions in three dimensions delivered by the Leksell gamma knife. The irradiation unit is used to selectively treat small volumes in the brain with single high doses of ionising radiation--a treatment procedure known as radiosurgery. The dosimetry method investigated utilises a dosimeter gel consisting of ferrous sulphate solution and agarose which is, prior to irradiation, loaded into a cavity in a spherical phantom. Chemical changes induced in the gel by the radiation are measured by means of an MR-scanner. This imaging method permits rapid evaluation of the dose distribution in an irradiated volume. It thus offers a potential verification of individual radiation intracranial target treatment regimes as well as quality assurance measurements, assuming that the precision and accuracy of the dose mapping are adequate. The dose and its distribution registered by the gel dosimeter, in this initial experiment, are in good agreement with corresponding computed data obtained with the KULA treatment planning system of the gamma knife. The gel has thus the potential of being an attractive alternative dose mapping method to those used at present in radiosurgery, i.e. radiographic film and small ionisation chambers. The precision of the dosimeter gel is, however, not yet sufficient high to be used as a basic dosimetry system for the gamma knife.     

Radiosurgery and the double logistic product formula

The double logistic product formula is proposed as a method for predicting the probability of developing brain necrosis after high dose irradiation of small target volumes as used in stereotactic radiosurgery. Dose-response data observed for the production of localized radiation necrosis for treating intractable pain with the original Leksell gamma unit were used to choose the best fitting parameters for the double logistic product formula. This model can be used with either exponential or linear quadratic formulas to account for the effects of dose, fractionation and time in addition to volume. Dose-response predictions for stereotactic radiosurgery with different sized collimators are presented.     

Heavy charged-particle stereotactic radiosurgery: cerebral angiography and CT in the treatment of intracranial vascular malformations

A method is described for stereotactic localization of intracranial arteriovenous malformations (AVM) and for calculating treatment plans for heavy charged-particle Bragg peak radiosurgery. A stereotactic frame and head immobilization system is used to correlate the images of multivessel cerebral angiography and computed tomography. The AVM is imaged by angiography, and the frame provides the stereotactic coordinates for transfer of this target to CT images for the calculation of treatment plans. The CT data are used to calculate the residual ranges and compensation for the charged-particle beam required for each treatment port. Three-dimensional coordinates for the patient positioner are calculated, and stereotactic radiosurgery is performed. Verification of the accuracy of the stereotactic positioning is obtained with computer-generated overlays of the vascular malformation, stereotactic fiducial markers, and bony landmarks on orthogonal radiographs immediately prior to treatment. Using these procedures, the accuracy of the repositioning of the patient at each of a series of imaging and treatment procedures is typically within 1 mm in each of three orthogonal planes.     

An Overview of CyberKnife Radiosurgery

Stereotactic radiosurgery is a non-invasive procedure that utilizes precisely targeted radiation as an ablative surgical tool. Conventional radiosurgery devices, such as the Gamma Knife, rely upon skeletally attached Stereotactic frames to immobilize the patient and precisely determine the 3D spatial position of a tumor. A relatively new instrument, the CyberKnife (Accuray, Inc., Sunnyvale, CA), makes it possible to administer radiosurgery without a frame. The CyberKnife localizes clinical targets using a very accurate image-to-image correlation algorithm, and precisely cross-fires high-energy radiation from a lightweight linear accelerator by means of a highly manipulable robotic arm. CyberKnife radiosurgery is an effective alternative to conventional surgery or radiation therapy for a range of tumors and some non-neoplastic disorders. This report will describe CyberKnife technology and oncologic applications in neurosurgery and throughout the body.     

An integrated logistic formula for prediction of complications from radiosurgery

An integrated logistic model for predicting the probability of complications when small volumes of tissue receive an inhomogeneous radiation dose is described. This model can be used with either an exponential or linear quadratic correction for dose per fraction and time. Both the exponential and linear quadratic versions of this integrated logistic formula provide reasonable estimates of the tolerance of brain to radiosurgical dose distributions where there are small volumes of brain receiving high radiation doses and larger volumes receiving lower doses. This makes it possible to predict the probability of complications from stereotactic radiosurgery, as well as combinations of fractionated large volume irradiation with a radiosurgical boost. Complication probabilities predicted for single fraction radiosurgery with the Leksell Gamma Unit using 4, 8, 14, and 18 mm diameter collimators as well as for whole brain irradiation combined with a radiosurgical boost are presented. The exponential and linear quadratic versions of the integrated logistic formula provide useful methods of calculating the probability of complications from radiosurgical treatment.     

Image registration of BANG gel dose maps for quantitative dosimetry verification

Background: The BANG® (product symbol SGEL, MGS Research Inc., Guilford, CT) polymer gel has been shown to be a valuable dosimeter for determining three-dimensional (3D) dose distributions. Because the proton relaxation rate (R2) of the gel changes as a function of absorbed dose, MR scans of the irradiated gel can be used to generate 3D dose maps. Previous work with the gel, however, has not relied on precise localization of the measured dose distribution. This has limited its quantitative use, as no precise correlation exists with the planned distribution. This paper reports on a technique for providing this correlation, thus providing a quality assurance tool that includes all of the steps of imaging, treatment planning, dose calculation, and treatment localization.

Methods and Materials: The BANG® gel formulation was prepared and poured into spherical flasks (15.3-cm inner diameter). A stereotactic head ring was attached to each flask. Three magnetic resonance imaging (MRI) and computed tomography (CT) compatible fiducial markers were placed on the flask, thus defining the central axial plane. A high-resolution CT scan was obtained of each flask. These images were transferred to a radiosurgery treatment-planning program, where treatment plans were developed. The gels were irradiated using our systems for stereotactic radiosurgery or fractionated stereotactic radiotherapy. The gels were MR imaged, and a relative 3D dose map was created from an R2 map of these images. The dose maps were transferred to an image-correlation program, and then fused to the treatment-planning CT scan through a rigid body match of the MRI/CT-compatible fiducial markers. The fused dose maps were imported into the treatment-planning system for quantitative comparison with the calculated treatment plans.

Results: Calculated and measured isodose surfaces agreed to within 2 mm at the worst points within the in-plane dose distributions. This agreement is excellent, considering that the pixel resolution of the MRI dose maps is 1.56 × 1.56 mm, and the treatment-planning dose distributions were calculated on a 1-mm dose grid. All points within the dose distribution were well within the tolerances set forth for commissioning and quality assurance of stereotactic treatment-planning systems. Moreover, the quantitative evaluation presented here tests the accuracy of the entire treatment-planning and delivery process, including stereotactic frame rigidity, CT localization, CT/MR correlation, dose calculation, and radiation delivery.

Conclusion: BANG® polymer gel dosimetry coupled with image correlation provides quantitative verification of the accuracy of 3D dose distributions. Such quantitative evaluation is imperative to ensure the high quality of the 3D dose distributions generated and delivered by stereotactic and other conformal irradiation systems.     

Stereotactic radiosurgery for brain tumors.

In the 50 years since Leksell developed the concepts and initial hardware for modern brain radiosurgery, the treatment has progressed to the point where it is used commonly for arteriovenous malformations, benign masses, and metastases. Radiosurgery offers patients an effective treatment of life-threatening lesions with a reasonably low risk for discomfort and injury. In the 1990s, the procedure was used widely as primary and adjuvant treatment. The difficulty of defining the boundaries of primary brain cancers makes determining treatment targets problematic. Better imaging and computing offer a bright future for the technology.     

Stereotactic frame for neuroradiology and charged particle Bragg peak radiosurgery of intracranial disorders

The application of heavy charged particle Bragg peak radiosurgery for the treatment of intracranial vascular and other disorders requires a system of precise patient immobilization and stereotactic localization of defined intracranial targets. The process of using stereotactic neuroradiological procedures (including cerebral angiography, CT scanning and magnetic resonance imaging) for target definition and localization, and complex treatment planning constrain such a system to be adaptable and reusable. This paper describes a removable stereotactic frame-mask system that is used to immobilize and reposition the patient during stereotactic neuroradiological procedures and charged particle radiosurgery. It consists of four parts--(a) a plastic mask for immobilizing the patient's head; (b) a lucite-graphite mounting frame; (c) a set of fiducial markers; and (d) interfaces between the frame for immobilization and fixation to various diagnostic and therapeutic patient couches. The relationship between each component and the radiosurgical procedure is discussed. This system has proven to be safe, reliable, and noninvasive and it does not require fixation to the bones of the face or skull. When integrated into the radiosurgical treatment planning and localization procedures developed at Lawrence Berkeley Laboratory, it is capable of reliably repositioning the patient to 1 mm in each of three planes and contouring the intracranial target reliably to this accuracy. The application of this stereotactic system in heavy charged particle radiosurgery of intracranial arteriovenous malformations is described in other reports.     

Risk analysis of Leksell Gamma Knife Model C with automatic positioning system

PURPOSE: This study was conducted to evaluate the decrease in risk from misadministration of the new Leksell Gamma Knife Model C with Automatic Positioning System compared with previous models. METHODS AND MATERIALS: Elekta Instruments, A.B. of Stockholm has introduced a new computer-controlled Leksell Gamma Knife Model C which uses motor-driven trunnions to reposition the patient between isocenters (shots) without human intervention. Previous models required the operators to manually set coordinates from a printed list, permitting opportunities for coordinate transposition, incorrect helmet size, incorrect treatment times, missing shots, or repeated shots. RESULTS: A risk analysis was conducted between craniotomy involving hospital admission and outpatient Gamma Knife radiosurgery. A report of the Institute of Medicine of the National Academies dated November 29, 1999 estimated that medical errors kill between 44,000 and 98,000 people each year in the United States. Another report from the National Nosocomial Infections Surveillance System estimates that 2.1 million nosocomial infections occur annually in the United States in acute care hospitals alone, with 31 million total admissions. CONCLUSIONS: All medical procedures have attendant risks of morbidity and possibly mortality. Each patient should be counseled as to the risk of adverse effects as well as the likelihood of good results for alternative treatment strategies. This paper seeks to fill a gap in the existing medical literature, which has a paucity of data involving risk estimates for stereotactic radiosurgery.     

The CyberKnife®

Stereotactic radiosurgery has emerged as an accepted treatment for many types of intracranial tumors. Based on the understanding of the limitations of prior radiosurgical systems, image-guided robotic radiosurgery was developed to overcome many of these restrictions. The CyberKnife® is a commercially available frameless image-guided radiosurgical system that provides state-of-the-art radiosurgery for intracranial tumors, and has also revolutionized the use of radiosurgery to treat tumors in other parts of the body. This review focuses on the current use of the CyberKnife® to treat cranial and spinal tumors. Brain metastases have long been treated with other radiosurgical systems, but the CyberKnife® allows patients with brain metastases to be treated multiple times as successive tumors are discovered, without the repetitive placement of a stereotactic head frame. Benign tumors such as acoustic neuromas, pituitary tumors, and meningiomas are also easily treated with the CyberKnife®, with radiographic tumor-control rates of >90% for pituitary tumors and 95% for acoustic neuromas and meningiomas. A subset of meningiomas and pituitary tumors surround the optic nerves and are considered to be perioptic tumors. Historically, these tumors have not been treatable with radiosurgery because of the risk of visual loss. The frameless nature of the CyberKnife® allows the radiosurgery treatment to be delivered in separate stages (typically 24 hours apart); this has been shown to significantly reduce the risk of visual loss, and thus allows effective radiosurgery treatment to be delivered. Staged radiosurgery treatment has also been used at our institution to treat acoustic neuromas, with the understanding that several stages of radiation delivery may be associated with a higher level of hearing preservation than a single-staged radiosurgery treatment. Malignant gliomas and nasopharyngeal carcinoma tumors have historically been treated with conventional radiotherapy techniques. However, we have learnt that supplementing these radiotherapy treatments with a CyberKnife® stereotactic boost after radiotherapy can improve response rates to treatment. Spinal radiosurgery is a novel development; prior frame-based radiosurgery devices did not allow treatment of lesions outside the brain and neck. We have observed high rates of tumor control when treating benign spinal tumors with the CyberKnife®, and have noted excellent pain relief and tumor-control rates in patients with spinal metastases. Future CyberKnife® stereotactic applications will focus on the continual expansion of this technology to treat tumors outside the CNS, including cancers of the lung, pancreas, liver, and prostate.     

Historique de la radiochirurgie

Within the last decades, radiosurgery, also known as stereotactic radiotherapy, has become more and more popular as a non-invasive treatment of small benign tumours, arteriovenous malformations, metastases, and also some functional neurological structures, such as the fifth cranial nerve for trigeminal neuralgesia. It allows precisely delivering very high dose in a small volume under stereotactic conditions with minimal irradiation of tissue around the area. The first equipment devoted to radiosurgery was the Leksell Gamma Knife^®. It is now challenged by some linear accelerators providing radiosurgery technology, such as the CyberKnife^®, the Novalis Tx^® radiosurgery platform, and the True Beam^® linear accelerator.